# LISDEXAMFETAMINE DIMESYLATE

NDC: 31722-352
Generic name: Lisdexamfetamine dimesylate
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240909

FDA application: ANDA217442

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-352"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-352
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=20baa61e-be0b-41a3-a896-29e8ce8c4799